Phase
Condition
Congestive Heart Failure
Angina
Myocardial Ischemia
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Suspected anterior STEMI: new ST-elevation > 0.1 millivolt (mV) (≥ 0.2 mV in men or ≥ 0.15 mV in women in leads V2-V3) in > two contiguous leads in V1-V6; new or presumednew left bundle branch block;
Symptom onset no more than 12 h before presentation and planned primary PCI;
Age 18 to 75 years;
Willingness and capability to provide informed consent.
Exclusion
Exclusion Criteria:
Previous anterior myocardial infarction;
Previous coronary artery bypass graft (CABG);
Myocardial infarction or stroke within the previous 30 days;
Treatment with thrombolysis within the previous 30 days;
Cardiogenic shock;
Thrombolysis in myocardial infarction (TIMI) flow grade 2 or 3 at coronaryangiography;
Coronary anatomy or mechanical complication of STEMI (ventricular septal rupture, freewall rupture, acute severe mitral regurgitation) warranting emergent surgery;
Inability to obtain TIMI flow grade ≥ 2;
Conditions precluding use of RIC (paresis of lower limb, known severe peripheralartery disease or evidence of lower limb ischemia, and etc.);
Life expectancy of less than 12 months due to non-cardiac disease such as knownmalignancy or other comorbid conditions;
Contraindications to CMR;
Treated with therapeutic hypothermia before admission;
Pregnancy and lactating women;
Participation in another interventional trial.
Study Design
Study Description
Connect with a study center
Chinese Academy of Medical Sciences, Fuwai Hospital
Beijing, Beijing 100037
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.